BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013

Jun 3, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-05-31

Reporting Person: ABERCROMBIE GEORGE B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-31	Automatic Stock Option Grant	$1.71	A	15000	Acquired	2023-05-31	Common Stock (15000)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan.

F2: Vests 1/12 per month over 12 months beginning June 30, 2013.